← Evidence map

ArticleCancer2018

The evolution of dasatinib dosage over the years and its relevance to other anticancer medications.

Charles A SchifferPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2018
2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29723416